4.8 Letter

Maraviroc and JC Virus-Associated Immune Reconstitution Inflammatory Syndrome

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 370, Issue 5, Pages 486-488

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc1304828

Keywords

-

Funding

  1. Canadian Institutes of Health Research [113558-1] Funding Source: Medline

Ask authors/readers for more resources

The immune reconstitution inflammatory syndrome can be a serious complication of immune reversal in the treatment of progressive multifocal leukoencephalopathy. A new potential treatment for IRIS is described in this letter.To the Editor: The immune reconstitution inflammatory syndrome (IRIS) can be a serious complication in immunocompromised patients in whom progressive multifocal leukoencephalopathy (PML) has developed. IRIS occurs in such patients when their immunocompromised state reverses.(1) Although restored immune surveillance is vital for clearing the JC virus that causes PML, improved management strategies for IRIS are needed because of its potential for considerable complications and death. The common, though unproven, use of glucocorticoids to treat IRIS may limit JC viral clearance.(2) Because of the indirect implication of chemokine receptor 5-positive (CCR5+) T cells in IRIS pathophysiology,(3) we used the small-molecule CCR5 ...

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available